These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2305080)

  • 1. Appropriate use of names for MR contrast media.
    Goldstein HA
    Radiology; 1990 Mar; 174(3 Pt 1):897. PubMed ID: 2305080
    [No Abstract]   [Full Text] [Related]  

  • 2. Childhood chondrosarcoma: MR imaging with gadolinium-DTPA.
    Hanna SL; Magill HL; Parham DM; Bowman LC; Fletcher BD
    Magn Reson Imaging; 1990; 8(5):669-72. PubMed ID: 2082141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gd-DTPA enhancement in MR imaging of central pontine myelinolysis.
    Koch KJ; Smith RR
    AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S58. PubMed ID: 2505569
    [No Abstract]   [Full Text] [Related]  

  • 4. Gd-DTPA-enhanced MR of multiple cryptococcal brain abscesses.
    Riccio TJ; Hesselink JR
    AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S65-6. PubMed ID: 2505575
    [No Abstract]   [Full Text] [Related]  

  • 5. Gd-DTPA-enhanced MR imaging of cochlear schwannoma.
    Brogan M; Chakeres DW
    AJNR Am J Neuroradiol; 1990; 11(2):407-8. PubMed ID: 2107728
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical applications of gadolinium-DTPA in MRI.
    de Roos A; Doornbos J; Baleriaux D; Bloem HL; Falke TH
    Magn Reson Annu; 1988; ():113-45. PubMed ID: 3079294
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 8. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
    Schubeus P; Schörner W; Haustein J
    Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
    [No Abstract]   [Full Text] [Related]  

  • 9. Contrast-enhanced MR imaging of the female pelvis.
    Hricak H; Kim B
    J Magn Reson Imaging; 1993; 3(1):297-306. PubMed ID: 8428097
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations in the choice of contrast media for MR imaging.
    Brasch RC; Bennett HF
    Radiology; 1988 Mar; 166(3):897-9. PubMed ID: 3340795
    [No Abstract]   [Full Text] [Related]  

  • 11. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 12. Gd-DTPA as a contrast agent in CT.
    Bloem JL; Wondergem J
    Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.
    Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW
    Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging of brain perfusion using the nonionic contrast agents Dy-DTPA-BMA and Gd-DTPA-BMA.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Moseley M; Watson A; Rocklage S
    Invest Radiol; 1991 Nov; 26 Suppl 1():S250-2; discussion S253-4. PubMed ID: 1808141
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration.
    Wang SC; White DL; Pope JM; Brasch RC
    Invest Radiol; 1990 Sep; 25 Suppl 1():S44-5. PubMed ID: 2283253
    [No Abstract]   [Full Text] [Related]  

  • 16. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
    Kransdorf MJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
    [No Abstract]   [Full Text] [Related]  

  • 17. Gd-DTPA in MR of spinal lesions.
    Katz CT; Brody WR
    Invest Radiol; 1989 Nov; 24(11):937-40. PubMed ID: 2807814
    [No Abstract]   [Full Text] [Related]  

  • 18. Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MR imaging.
    Fletcher BD; Hanna SL
    Radiology; 1990 Oct; 177(1):287-8. PubMed ID: 2399334
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging of neurocutaneous melanosis.
    Rhodes RE; Friedman HS; Hatten HP; Hockenberger B; Oakes WJ; Tomita T
    AJNR Am J Neuroradiol; 1991; 12(2):380-2. PubMed ID: 1902050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rapid MR measurement of contrast medium dilution techniques (Gd-DTPA) in a cardiovascular phantom].
    Böck JC; Sander B; Frank J; Schörner W; Felix R
    Biomed Tech (Berl); 1990; 35 Suppl 3():249-50. PubMed ID: 2078717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.